Inhibition of p38MAP kinase potentiates the JNK/SAPK pathway and AP-1 activity in monocytic but not in macrophage or granulocytic differentiation of HL60 cells

Journal of Cellular Biochemistry

Volumn 82, Issue 1, 2001, Pages 68-77

  Velders, Markwin P ^a   Fatima Macedo, M ^b   Provenzano, Maurizio ^a   Elmishad, Amira G ^a   Holzhütter, Hermann Georg ^b   Carbone, Michele ^b   Martin Kast, W ^a  

^a LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

1,25 dihydroxyvitamin D3; Differentiation; DMSO; MAP kinase pathways; Retinoic acid; TPA

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GRANULOCYTE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MACROPHAGE ACTIVATION; MONOCYTE; ONCOGENE MYC; PRIORITY JOURNAL; PROTO ONCOGENE; RECEPTOR UPREGULATION; TUMOR SUPPRESSOR GENE;

ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTIGENS, SURFACE; CALCITRIOL; CELL CYCLE; CELL DIFFERENTIATION; CELL SURVIVAL; DIMETHYL SULFOXIDE; GRANULOCYTES; HL-60 CELLS; HUMANS; IMIDAZOLES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MACROPHAGES; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

EID: 0034981648     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.1141     Document Type: Article

References (39)

1. Rapid micropreparation technique for extraction of DNA binding proteins from limiting numbers of mammalian cells
2. Serum-induced monocyte differentiation and monocyte chemotaxis are regulated by the p38MAP kinase signal transduction pathway
3. Pyridine nucleotide-dependent superoxide production by a cell-free system from human granulocytes
4. The p38MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway
5. The p38 pathway provides negative feedback to RAS proliferative signaling
6. Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide
7. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1
8. Oncogene amplification in promyelocytic leukemia cell line HL-60 and primary leukemic cells of the same patient
9. Activation of the p38 mitogen-activated protein kinase pathway arrests cell cycle progression and differentiation of immature thymocytes in vivo
10. Defective T cell differentiation in the absence of JNK1
11. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6
12. The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pryidinylimidazole inhibitor binding
13. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia
14. Evaluation of the expression of NADPH oxidase components during maturation of HL60 cells to neutrophil lineage
15. NB4 cells show bilineage potential and an aberrant pattern of neutrophil secondary granule protein gene expression
16. The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase
17. 3 inhibits proliferation of human promyelocytic leukemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells
18. The HL-60 transforming sequence: A ras oncogene coexisting with altered myc genes in hematopoietic tumors
19. p38 kinase-dependent MAPKAPK-2 activation functions as PDK2 for AKT in human neutrophils
20. Induction of differentiation in human promyelocytic leukemia cells by tumor promoters
21. Granulocyte-macrophage colony-stimulating factor induces the expression of the CD11b surface adhesion molecule on human granulocytes in vivo
22. A system for monocytic differentiation of leukemic cells HL 60 by a short exposure to 1,25-dihydroxycholecalciferol
23. 3-resistant HL 60 cells is preceded by reduced growth factor dependence and constitutive up-regulation of Sp1 and AP-1 transcription factors
24. Uncoupling of cell cycle arrest from the expression of monocytic differentiation markers in HL60 cell variants
25. 3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytes
26. Growth and activation of human leukaemic cells in vitro and their growth in the SCID mouse model
27. 3-induced differentiation of HL60 cells
28. Synergistic induction of HL60 cell differentiation by ketoconazole and 1-desoxy analogues of vitamin D
29. 3 reverses the G1 block but not differentiation of HL 60 cells
30. 3-induced differentiation of human leukemia HL60 cells
31. Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38MAP kinase pathways
32. Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells
33. Cytochemical identification of monocytes and granulocytes
34. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest
35. Retinoic acid selectively activates the ERK2 but not NJK/SAPK or p38MAP kinases when inducing myeloid differentiation
36. p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor
37. 3
38. 3 precedes the G1/G0 phase ell cycle block
39. CD14: Cell surface receptor and differentiation marker